Published in
Elsevier, Lung Cancer, (151), p. 69-75, 2021
DOI: 10.1016/j.lungcan.2020.11.008
Links
Tools
PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project
Journal article published in 2020 by
H. Blons 
,
J.-B. Oudart,
J.-P. Merlio ,
D. Debieuvre,
F. de Fraipont,
C. Audigier-Valette,
F. Escande,
S. Hominal,
P.‐P Bringuier ,
S. Fraboulet-Moreau,
L. Ouafik ,
D. Moro-Sibilot,
A. Lemoine,
A. Langlais,
P. Missy
and other authors.
,
J.-B. Oudart,
J.-P. Merlio ,
D. Debieuvre,
F. de Fraipont,
C. Audigier-Valette,
F. Escande,
S. Hominal,
P.‐P Bringuier ,
S. Fraboulet-Moreau,
L. Ouafik ,
D. Moro-Sibilot,
A. Lemoine,
A. Langlais,
P. Missy
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 